Replies to post #1294 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Agreed mayvid...killer wait for ALL bio-med co's due to the FDA's +2800 backlog of ANDA's...but when one takes into account ALL of the valuation drivers in IPCI's immediate pipeline it's beyond a no brainer that this is going to be our year here!!!

Here's a quick handful of to me what will be the key valuation and exposure driving announcements between now and this summer choo-choo>>>

- 2 new ANDA's expected to be filed this year bringing IPCI's total ANDA's up to 10

- Pending FDA approval of IPCI's 1st ANDA

- 2 more FDA approvals slated for FDA approval THIS YEAR giving IPCI a total of 3 FDA ANDA approvals slated for this year

- Ringing of the NAZ opening bell immediately upon the news of the FDA's expected approval of IPCI's 1st ever ANDA

- 2 lucrative partnership/licensing agreements will be secured and announced on IPCI's ANDA's number 2 and 3 immediately following the FDA approval of ANDA number 1 = FocalinXR